Skip to main navigation menu Skip to main content Skip to site footer
Plant Science Today (PST)

Review Articles

Vol. 12 No. 2 (2025)

A thorough assessment on the recent pharmacological and therapeutic potential of ellagic acid

DOI
https://doi.org/10.14719/pst.8273
Submitted
14 March 2025
Published
26-05-2025 — Updated on 10-06-2025
Versions

Abstract

This review comprehensively examines the pharmacological and therapeutic potential of ellagic acid (EA). A systematic literature search was conducted in PubMed and Google Scholar, employing keywords related to EA’s biological sources, derivatives and efficacy focusing on studies published up to February 2025. Inclusion criteria encompassed original research and mechanistic reviews in English, while editorials, non-English publications and studies lacking direct EA focus or sufficient data were excluded. EA, a dietary polyphenol, exhibits potent antioxidant and anti-inflammatory activities, demonstrating therapeutic potential across various disease areas. Mechanistically, EA modulates key signalling pathways like NF-κB, MAPK and Nrf2/ARE, impacting cellular processes such as apoptosis, oxidative stress and inflammation. Preclinical studies highlight EA’s efficacy in combating cancer (inhibiting tumor growth and metastasis), cardiovascular diseases (ameliorating mitochondrial dysfunction and oxidative stress), neurodegenerative disorders (enhancing neuronal viability and reducing neuroinflammation), diabetes (improving glucose homeostasis), liver and kidney pathologies (reducing fibrosis and oxidative damage) and fertility (modulating reproductive hormones and sperm protection). Additionally, EA demonstrates cytoprotective and anti-ulcer effects, protecting against cellular damage and gastric mucosa injury. EA presents a promising therapeutic agent with diverse pharmacological activities. Its ability to modulate multiple signalling pathways and exert protective effects against various pathologies underscores its potential. Further studies will validate efficacy, optimize delivery and explore synergistic effects, ultimately translating preclinical findings into effective clinical applications.

References

  1. 1. Jun H, Han JH, Hong M, Fitriana F, Syahada JH, Lee WJ, et al. Ellagic Acid from Geranium thunbergii and antimalarial activity of Korean medicinal plants. Molecules. 2025;30(2):359. https://doi.org/10.3390/molecules30020359
  2. 2. Longevity OMAC. Retracted: Ellagic Acid: A review on its natural sources, chemical stability, and therapeutic potential. Oxid Med Cell Longev. 2024;1:9801541. https://doi.org/10.1155/2024/9801541
  3. 3. Sun Y, Hu X, Wang Y. Ellagic acid ameliorates ovarian cancer via modification of pyroptosis and inflammation. Iran J Allergy Asthma Immunol. 2024;8:1-5. https://doi.org/10.18502/ijaai.v24i1.18025
  4. 4. Aishwarya V, Solaipriya S, Sivaramakrishnan V. Role of ellagic acid for the prevention and treatment of liver diseases. Phytother Res. 2021;35(6):2925-44. https://doi.org/10.1002/ptr.7001
  5. 5. Li P, Zhao S, Teng Y, Han S, Yang Y, Wu M, et al. Dietary supplementary with ellagic acid improves the intestinal barrier function and flora structure of broiler chicken challenged with E. coli K88. Poult Sci. 2024;103(12):104429. https://doi.org/10.1016/j.psj.2024.104429
  6. 6. Lu J, Ding K, Yuan Q. Determination of punicalagin isomers in pomegranate husk. Chromatographia. 2008;68:303-6. https://doi.org/10.1365/s10337-008-0699-y
  7. 7. Unnikrishnan J, Hegde M, Girisa S, Satpati P, Kunnumakkara AB. Ellagic acid-gold nanoparticle complex as anticancer agent in Triple-negative breast cancer cells. Nano LIFE. 2024;14(02):2450003. https://doi.org/10.1142/s179398442450003x
  8. 8. Golmei P, Kasna S, Roy KP, Kumar S. A review on pharmacological advancement of ellagic acid. J Pharm Pharmacol. 2024;15(2):93-104. https://doi.org/10.1177/0976500x241240634
  9. 9. Zhang HM, Zhao L, Li H, Xu H, Chen WW, Tao L. Research progress on the anticarcinogenic actions and mechanisms of ellagic acid. Cancer Biol Med. 2014;11(2):92-100.
  10. 10. Nguyen V, Taine EG, Meng D, Cui T, Tan W. Chlorogenic acid: A systematic review on the biological functions, mechanistic actions, and therapeutic potentials. Nutrients. 2024;16(7):924. https://doi.org/10.3390/nu16070924
  11. 11. Agrawal OD, Kulkarni YA. Mini-review of analytical methods used in quantification of ellagic acid. Rev Anal Chem. 2020;39(1):31-44. https://doi.org/10.1515/revac-2020-0113
  12. 12. Losso JN, Bansode RR, Trappey II A, Bawadi HA, Truax R. In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem. 2004;15(11):672-8. https://doi.org/10.1016/j.jnutbio.2004.06.004
  13. 13. Heber D. Pomegranate Ellagitannins; 2023. https://www.ncbi.nlm.nih.gov/books/NBK92772/
  14. 14. Zuccari G, Baldassari S, Ailuno G, Turrini F, Alfei S, Caviglioli G. Formulation strategies to improve oral bioavailability of ellagic acid. Appl Sci. 2020;10(10):3353. https://doi.org/10.3390/app10103353
  15. 15. Wan ML, Co VA, El-Nezami H. Dietary polyphenol impact on gut health and microbiota. Crit Rev Food Sci Nutr. 2021;61(4):690-711. https://doi.org/10.1080/10408398.2020.1744512
  16. 16. Lu G, Wang X, Cheng M, Wang S, Ma K. The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art. Biomed Pharmacother. 2023;165:115132. https://doi.org/10.1016/j.biopha.2023.115132
  17. 17. Hou C, Chen L, Yang L, Ji X. An insight into anti-inflammatory effects of natural polysaccharides. Int J Biol Macromol 2020;153:24855. https://doi.org/10.1016/j.ijbiomac.2020.02.315
  18. 18. Gil TY, Hong CH, An HJ. Anti-inflammatory effects of ellagic acid on keratinocytes via MAPK and STAT pathways. Int J Mol Sci. 2021;22(3):1277. https://doi.org/10.3390/ijms22031277
  19. 19. Alexova R, Alexandrova S, Dragomanova S, Kalfin R, Solak A, Mehan S, et al. Anti-COVID-19 potential of ellagic acid and polyphenols of Punica granatum L. Molecules. 2023;28(9):3772. https://doi.org/10.3390/molecules28093772
  20. 20. Bhattacharjee A, Kulkarni VH, Chakraborty M, Habbu PV, Ray A. Ellagic acid restored lead-induced nephrotoxicity by anti-inflammatory, anti-apoptotic and free radical scavenging activities. Heliyon. 2021;7(1):e05921. https://doi.org/10.1016/j.heliyon.2021.e05921
  21. 21. Lin Z, Lin C, Fu C, Lu H, Jin H, Chen Q, et al. The protective effect of ellagic acid (EA) in osteoarthritis: An in vitro and in vivo study. Biomed. Pharmacother. 2020;125:109845. https://doi.org/10.1016/j.biopha.2020.109845
  22. 22. Murphy MT, Qin X, Kaul S, Barrientos G, Zou Z, Mathias CB, et al. The polyphenol ellagic acid exerts anti-inflammatory actions via disruption of store-operated calcium entry (SOCE) pathway activators and coupling mediators. Eur J Pharmacol 2020;875:173036. https://doi.org/10.1016/j.ejphar.2020.173036
  23. 23. Derosa G, Maffioli P, Sahebkar A. Ellagic acid and its role in chronic diseases. In: Gupta S, Prasad S, Aggarwal B, editors. Anti-inflammatory nutraceuticals and chronic diseases. Vol. 928. Springer, Cham.; 2016. p. 473-9. https://doi.org/10.1007/978-3-319-41334-1_20
  24. 24. Kim JY, Choi YJ, Kim HJ. Determining the effect of ellagic acid on the proliferation and migration of pancreatic cancer cell lines. Transl Cancer Res. 2021;10(1):424. https://doi.org/10.21037/tcr-20-2446
  25. 25. Čižmáriková M, Michalková R, Mirossay L, Mojžišová G, Zigová M, Bardelčíková A, et al. Ellagic acid and cancer hallmarks: insights from experimental evidence. Biomolecules. 2023;13(11):1653. https://doi.org/10.3390/biom13111653
  26. 26. Jin X, Ying J, Ni J, Gao Z, Zhang X. Anti-lung cancer targets of ellagic acid and biological interaction with a blood carrier protein. Arab J Chem. 2024;17(5):105725. https://doi.org/10.1016/j.arabjc.2024.105725
  27. 27. Chauhan A, Yadav M, Chauhan R, Basniwal RK, Pathak VM, Ranjan A, et al. Exploring the potential of ellagic acid in gastrointestinal cancer prevention: recent advances and future directions. Oncol Ther. 2024;12(4):685-99. https://doi.org/10.1007/s40487-024-00296-1
  28. 28. Mandal T, Shukla D, Pattanayak S, Barman R, Ashraf R, Dixit AK, et al. Ellagic acid induces DNA damage and apoptosis in cancer stem-like cells and overcomes cisplatin resistance. ACS Omega. 2024;9(50):48988-9000. https://doi.org/10.1021/acsomega.3c08819
  29. 29. Li LW, Na C, Tian SY, Chen J, Ma R, Gao Y, et al. Ellagic acid induces HeLa cell apoptosis via regulating signal transducer and activator of transcription 3 signalling. Exp Ther Med. 2018;16(1):29-36. https://doi.org/10.3892/etm.2018.6182
  30. 30. Xia J, Xue C, Yu J. Ellagic acid inhibited cervical cancer growth via blocking the AKT/mTOR/STAT3 pathway. Arch Med Sci. 2020 https://doi.org/10.5114/aoms.2020.100837
  31. 31. Yousuf M, Shamsi A, Khan P, Shahbaaz M, AlAjmi MF, Hussain A, et al. Ellagic acid controls cell proliferation and induces apoptosis in breast cancer cells via inhibition of cyclin-dependent kinase 6. Int J Mol Sci. 2020;21(10):3526. https://doi.org/10.3390/ijms21103526
  32. 32. Wu YS, Ho JY, Yu CP, Cho CJ, Wu CL, Huang CS, et al. Ellagic acid resensitizes gemcitabine-resistant bladder cancer cells by inhibiting epithelial-mesenchymal transition and gemcitabine transporters. Cancers. 2021;13(9):2032. https://doi.org/10.3390/cancers13092032
  33. 33. Golmohammadi M, Zamanian MY, Jalal SM, Noraldeen SA, Ramírez‐Coronel AA, Oudaha KH, et al. A comprehensive review on Ellagic acid in breast cancer treatment: From cellular effects to molecular mechanisms of action. Food Sci Nutr. 2023;11(12):7458-68. https://doi.org/10.1002/fsn3.3699
  34. 34. Mallamaci R, Barbarossa A, Carocci A, Meleleo D. Evaluation of the potential protective effect of ellagic acid against heavy metal (cadmium, mercury, and lead) toxicity in SH-SY5Y neuroblastoma cells. Foods. 2024;13(3):419. https://doi.org/10.3390/foods13030419
  35. 35. Aprile M, Cataldi S, Perfetto C, Federico A, Ciccodicola A, Costa V. Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype. Br J Cancer. 2023;129(2):249-65. https://doi.org/10.1038/s41416-023-02282-2
  36. 36. Li J, Liao R, Zhang S, Weng H, Liu Y, Tao T, et al. Promising remedies for cardiovascular disease: Natural polyphenol ellagic acid and its metabolite urolithins. Phytomedicine. 2023;116:154867. https://doi.org/10.1016/j.phymed.2023.154867
  37. 37. Pei S, Zhao H, Chen L, He X, Hua Q, Meng X, et al. Preventive effect of ellagic acid on cardiac dysfunction in diabetic mice through regulating DNA hydroxymethylation. J Agric Food Chem. 2022;70(6):1902-10. https://doi.org/10.1021/acs.jafc.1c07574
  38. 38. Costa BM, Mengal V, Brasil GA, Peluso AA, Treebak JT, Endlich PW, et al. Ellagic acid prevents myocardial infarction-induced left ventricular diastolic dysfunctioninovariectomizedrats. J Nutr Biochem. 2022;105:108990. https://doi.org/10.1016/j.jnutbio.2022.108990
  39. 39. Falahieh KH, Sarkaki A, Edalatmanesh M, Naseri MK, Farbood Y. Ellagic acid attenuates post-cerebral ischemia and reperfusion behavioral deficits by decreasing brain tissue inflammation in rats. Iran J Basic Med Sci. 2020;23(5):645. https://doi.org/10.22038/ijbms.2020.41821.9882
  40. 40. Zhu H, Yan Y, Jiang Y, Meng X. Ellagic acid and its anti-aging effects on central nervous system. Int J Mol Sci. 2022;23(18):10937. https://doi.org/10.3390/ijms231810937
  41. 41. Baluchnejadmojarad T, Roghani M. Exploring the molecular mechanisms underlying neuroprotective effect of ellagic acid in okadaic acid-induced Alzheimer’s phenotype. Metab Brain Dis. 2024;39(7):1417-32. https://doi.org/10.1007/s11011-024-01405-9
  42. 42. Wang W, Wang S, Liu Y, Wang X, Nie J, Meng X, et al. Ellagic acid: a dietary-derived phenolic compound for drug discovery in mild cognitive impairment. Front Aging Neurosci. 2022;14:925855. https://doi.org/10.3389/fnagi.2022.925855
  43. 43. Chen F, Lu K, Bai N, Hao Y, Wang H, Zhao X, et al. Oral administration of ellagic acid mitigates perioperative neurocognitive disorders, hippocampal oxidative stress, and neuroinflammation in aged mice by restoring IGF-1 signalling. Sci Rep. 2024;14(1):2509. https://doi.org/10.1038/s41598-024-53127-8
  44. 44. Ha W, Ma R, Kang JY, Iradukunda Y, Shi YP. Green and shape-tunable synthesis of ellagic acid crystalline particles by tannic acid for neuroprotection against oxidative stress. Biomater Sci. 2024;12(14):3610-21. https://doi.org/10.1039/d4bm00380b
  45. 45. Jha A, Chaube U. Ellagic acid improves the symptoms of early-onset Alzheimer’s disease: behavioral and physiological correlates. Heliyon. 2024. https://doi.org/10.2139/ssrn.4885470
  46. 46. Ahlawat J, Neupane R, Deemer E, Sreenivasan ST, Narayan M. Chitosan–ellagic acid nanohybrid for mitigating rotenone-induced oxidative stress. ACS Appl Mater Int. 2020;12(16):18964-77. https://doi.org/10.1021/acsami.9b21215
  47. 47. Naraki K, Rahbardar MG, Ajiboye BO, Hosseinzadeh H. The effect of ellagic acid on the metabolic syndrome: A review article. Heliyon. 2023;9(11):e21844. https://doi.org/10.1016/j.heliyon.2023.e21844
  48. 48. Kwok AL, Balasooriya H, Ng K. Efficacy of ellagic acid and ellagitannins on diabetes mellitus: A meta-analysis of preclinical and clinical trials. Food Biosci. 2023;53:102573. https://doi.org/10.1016/j.fbio.2023.102573
  49. 49. Ghadimi M, Foroughi F, Hashemipour S, Nooshabadi MR, Ahmadi MH, Yari MG, et al. Decreased insulin resistance in diabetic patients by influencing Sirtuin1 and Fetuin-A following supplementation with ellagic acid: a randomized controlled trial. Diabetol Metab Syndr. 2021;13:1-7. https://doi.org/10.1186/s13098-021-00633-8
  50. 50. Amor AJ, Gómez-Guerrero C, Ortega E, Sala-Vila A, Lázaro I. Ellagic acid as a tool to limit the diabetes burden: Updated evidence. Antioxidants. 2020;9(12):1226. https://doi.org/10.3390/antiox9121226
  51. 51. Ríos JL, Giner RM, Marín M, Recio MC. A pharmacological update of ellagic acid. Planta Med. 2018;84(15):1068-93. https://doi.org/10.1055/a-0633-9492
  52. 52. Wang K, Hao Z, Ma L, Zhang W, Mo J, Li L, et al. Nrf2-dependent hepatoprotective effect of ellagic acid in titanium dioxide nanoparticles-induced liver injury. Phytomedicine. 2024;135:156064. https://doi.org/10.2139/ssrn.4696491
  53. 53. Zhang X, Liu Y, Liu M, Ma Q, Hao Z, Tang S, et al. Ellagic acid supplementation ameliorates cisplatin-induced liver injury in mice by inhibiting the NF-κB pathway and activating the Nrf2/HO-1 pathway. One Health Adv. 2024;2(1):20. https://doi.org/10.1186/s44280-024-00056-w
  54. 54. Ramadan WS, Alkarim S, Moulay M, Alrefeai G, Alkudsy F, Hakeem KR, et al. Modulation of the tumor microenvironment by ellagic acid in rat model for hepatocellular carcinoma: a potential target against hepatic cancer stem cells. Cancers. 2023;15(19):4891. https://doi.org/10.3390/cancers15194891
  55. 55. ALTamimi JZ, Alshammari GM, AlFaris NA, Alagal RI, Aljabryn DH, Albekairi NA, et al. Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK. Pharm Biol. 2022;60(1):25-37. https://doi.org/10.1080/13880209.2021.1990969
  56. 56. ALTamimi JZ, AlFaris NA, Alshammari GM, Alagal RI, Aljabryn DH, Aldera H, et al. Ellagic acid protects against diabetic nephropathy in rats by regulating the transcription and activity of Nrf2. J Funct Foods. 2021;79:104397. https://doi.org/10.1016/j.jff.2021.104397
  57. 57. Shabani M, Bayrami D, Moghadam AA, Jamali Z, Salimi A. Pretreatment of ellagic acid protects ifosfamide-induced acute nephrotoxicity in rat kidneys: A mitochondrial, histopathological and oxidative stress approaches. Toxicol Rep. 2023;10:441-7. https://doi.org/10.1016/j.toxrep.2023.04.005
  58. 58. Chen JH, Wu PT, Chyau CC, Wu PH, Lin HH. The nephroprotective effects of hibiscus sabdariffa leaf and ellagic acid in vitro and in vivo models of hyperuricemic nephropathy. J Agric Food Chem. 2022;71(1):382-97. https://doi.org/10.1021/acs.jafc.2c05720
  59. 59. Bhaya MN, Keleş H. The protective effect of ellagic acid on cyclophosphamide induced renal damage in rats. Pakistan J Zool. 2022;55:2001-500. https://doi.org/10.17582/journal.pjz/20220203110224
  60. 60. Shooshtari MK, Sarkaki A, Rashno M, Hoseinynejad K. Renal protection by ellagic acid in a rat model of glycerol-induced acute kidney injury. Vet Res Forum. 2024;15(2):105-11. https://doi.org/10.30466/vrf.2023.2000658.3859
  61. 61. Huang PY, Hsieh YH, Ting YH, Lee CC, Tsai JP. Ellagic acid ameliorates renal fibrogenesis by blocking epithelial-to-mesenchymal transition. Tzu Chi Med J. 2024;36(1):59-66. https://doi.org/10.4103/tcmj.tcmj_106_23
  62. 62. Naghibi N, Sadeghi A, Movahedinia S, Rahimi Naiini M, Rajizadeh MA, Bahri F, et al. Ellagic acid ameliorates aging-induced renal oxidative damage through upregulating SIRT1 and NRF2. BMC Complement Med Ther. 2023;23(1):77. https://doi.org/10.1186/s12906-023-03907-y
  63. 63. Gupta A, Singh AK, Kumar R, Jamieson S, Pandey AK, Bishayee A. Neuroprotective potential of ellagic acid: a critical review. Adv Nutr. 2021;12(4):1211-38. https://doi.org/10.1093/advances/nmab007
  64. 64. Bidanchi RM, Lalrindika L, Khushboo M, Bhanushree B, Dinata R, Das M, et al. Antioxidative, anti-inflammatory and anti-apoptotic action of ellagic acid against lead acetate induced testicular and hepato-renal oxidative damages and pathophysiological changes in male Long Evans rats. Environ Pollut. 2022;302:119048. https://doi.org/10.1016/j.envpol.2022.119048
  65. 65. Aslan A, Gok O, Beyaz S, Arslan E, Erman O, Ağca CA. The preventive effect of ellagic acid on brain damage in rats via regulating of Nrf‐2, NF‐kB and apoptotic pathway. J Food Biochem. 2020;44(6):e13217. https://doi.org/10.1111/jfbc.13217
  66. 66. Jamshidi Z, Roohbakhsh A, Karimi G. An overview on the protective effects of ellagic acid against heavy metals, drugs, and chemicals. Food Sci Nutr. 2023;11(12):7469-84. https://doi.org/10.1002/fsn3.3704
  67. 67. Kumar R, Kumar V, Gurusubramanian G, Rathore SS, Roy VK. Ellagic acid mitigates heat-induced testicular detriment in a mouse model. J Steroid Biochem Mol Biol. 2024;243:106576. https://doi.org/10.1016/j.jsbmb.2024.106576
  68. 68. La Vignera S, Basile L, Aversa A, Calogero AE, Grillo A, Cannarella R, et al. The use of ellagic acid and Annona muricata improves semen quality in men with high-risk papillomavirus infection. J Clin Med. 2022;11(16):4691. https://doi.org/10.3390/jcm11164691
  69. 69. Sarode VV, Gautam S. Investigation of effect of ellagic acid on premature ovarian insufficiency. Ind J Pharm Pharmacol. 2024;11:29-37. https://doi.org/10.18231/j.ijpp.2024.006
  70. 70. Grba J, Kuželová L, Makarevich A, Baláži A, Dragin S, Tekić D, et al. The effect of ellagic acid on rabbit sperm in vitro parameters after cryopreservation. Czech J Anim Sci. 2024;69(3):110-7. https://doi.org/10.17221/142/2023-cjas
  71. 71. Başak Türkmen N, Ayhan I, Taşlıdere A, Aydın M, Çiftçi O. Investigation of protective effect of ellagic acid in phthalates-induced reproductive damage. Drug Chem Toxicol. 2022;45(4):1652-9. https://doi.org/10.1080/01480545.2020.1853764
  72. 72. Iovine C, Mottola F, Santonastaso M, Finelli R, Agarwal A, Rocco L. In vitro ameliorative effects of ellagic acid on vitality, motility and DNA quality in human spermatozoa. Mol Reprod Dev. 2021;88(2):167-74. https://doi.org/10.1002/mrd.23455
  73. 73. Mottola F, Iovine C, Carannante M, Santonastaso M, Rocco L. In vitro combination of ascorbic and ellagic acids in sperm oxidative damage inhibition. Int J Mol Sci. 2022;23(23):14751. https://doi.org/10.3390/ijms232314751
  74. 74. Khoshvaghti A, Rahbari R. The effect of ellagic acid on sex hormones and miRNA-21 expression in rats with polycystic ovary syndrome. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(6):4263-73. https://doi.org/10.21203/rs.3.rs-3273140/v1
  75. 75. Kazemi M, Lalooha F, Nooshabadi MR, Dashti F, Kavianpour M, Haghighian HK. Randomized double blind clinical trial evaluating the Ellagic acid effects on insulin resistance, oxidative stress and sex hormones levels in women with polycystic ovarian syndrome. J Ovarian Res. 2021;14:1-2. https://doi.org/10.1186/s13048-021-00849-2
  76. 76. Khoshvaghti A, Rahbari R. The effect of ellagic acid on sex hormones and miRNA-21 expression in rats with polycystic ovary syndrome. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(6):4263-73. https://doi.org/10.1007/s00210-023-02895-7
  77. 77. Xiong Y, Cheng Z, Zhang Y, Liu T, Wan Z, Xia C, et al. Ellagic acid alleviates DSS-induced ulcerative colitis by inhibiting ROS/NLRP3 pathway activation and modulating gut microbiota in mice. Eur J Nutr. 2025;64(1):1-7. https://doi.org/10.1007/s00394-024-03577-7
  78. 78. Zhou D, Yang Q, Tian T, Chang Y, Li Y, Duan LR, et al. Gastroprotective effect of gallic acid against ethanol-induced gastric ulcer in rats: involvement of the Nrf2/HO-1 signalling and anti-apoptosis role. Biomed Pharmacother. 2020;126:110075. https://doi.org/10.1016/j.biopha.2020.110075
  79. 79. Shams SG, Eissa RG. Amelioration of ethanol-induced gastric ulcer in rats by quercetin: implication of Nrf2/HO1 and HMGB1/TLR4/NF-κB pathways. Heliyon. 2022;8(10):e11159. https://doi.org/10.1016/j.heliyon.2022.e11159
  80. 80. Qiujian Y, Zongcai F, Liping H, Jingwei H, Zhongliu Z, Fang L. Ellagic acid (EA), a tannin was isolated from Eucalyptus citriodora leaves and its anti-inflammatory activity. Med Chem Res. 2021;30:2277-88. https://doi.org/10.1007/s00044-021-02806-6

Downloads

Download data is not yet available.